7Baggers

We provide you with 20 years of free, institutional-grade data for AQST stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AQST. Explore the full financial landscape of AQST stock.

Reported DateTickerType
2026-05-13AQST10-QUrl
2026-03-04AQST10-KUrl
2025-11-05AQST10-QUrl
2025-08-11AQST10-QUrl
2025-05-12AQST10-QUrl
2025-03-05AQST10-KUrl
2024-11-04AQST10-QUrl
2024-08-06AQST10-QUrl
2024-05-07AQST10-QUrl
2024-03-05AQST10-KUrl
2023-11-06AQST10-QUrl
2023-08-07AQST10-QUrl
2023-05-02AQST10-QUrl
2023-03-31AQST10-KUrl
2022-11-01AQST10-QUrl
2022-08-02AQST10-QUrl
2022-05-04AQST10-QUrl
2022-03-08AQST10-KUrl
2021-11-02AQST10-QUrl
2021-08-03AQST10-QUrl
2021-05-04AQST10-QUrl
2021-03-09AQST10-KUrl
2020-11-04AQST10-QUrl
2020-08-04AQST10-QUrl
2020-05-05AQST10-QUrl
2020-03-11AQST10-KUrl
2019-11-05AQST10-QUrl
2019-08-06AQST10-QUrl
2019-05-08AQST10-QUrl
2019-03-14AQST10-KUrl
2018-11-06AQST10-QUrl
2018-09-04AQST10-QUrl
2018-06-27AQSTS-1Url
2007-05-14AQSTS-1Url

Aquestive Therapeutics, Inc
(NASDAQ:AQST) 

AQST stock logo

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of le...

Founded: 2004
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
The information provided in this report about AQST stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.